Cronos Group Inc. (CRON)
USD 1.77
(-0.28%)
USD 1.77
(-0.28%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -73.96 Million USD | 55.43% |
| 2022 | -168.73 Million USD | 57.47% |
| 2021 | -396.7 Million USD | -431.63% |
| 2020 | -74.62 Million USD | -103.04% |
| 2019 | 2.45 Billion CAD | 17729.39% |
| 2018 | -13.92 Million CAD | -803.1% |
| 2017 | 1.98 Million CAD | 323.73% |
| 2016 | -885.4 Thousand CAD | -418.17% |
| 2015 | 278.27 Thousand CAD | 106.7% |
| 2014 | -4.15 Million CAD | -570.01% |
| 2013 | -619.47 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -8.75 Million USD | -292.52% |
| 2024 Q1 | -2.23 Million USD | 95.15% |
| 2023 Q4 | -46.04 Million USD | -2700.63% |
| 2023 Q2 | -8.36 Million USD | 56.59% |
| 2023 Q3 | -1.64 Million USD | 80.33% |
| 2023 Q1 | -19.25 Million USD | 75.58% |
| 2023 FY | -75.19 Million USD | 55.43% |
| 2022 Q4 | -78.85 Million USD | -113.79% |
| 2022 Q3 | -36.88 Million USD | -81.36% |
| 2022 Q2 | -20.33 Million USD | 37.71% |
| 2022 FY | -168.73 Million USD | 57.47% |
| 2022 Q1 | -32.65 Million USD | 75.57% |
| 2021 Q3 | 77.91 Million USD | 36.57% |
| 2021 Q4 | -133.63 Million USD | -271.51% |
| 2021 Q1 | -161.31 Million USD | -45.02% |
| 2021 FY | -396.7 Million USD | -431.63% |
| 2021 Q2 | 57.05 Million USD | 135.37% |
| 2020 Q1 | 76.04 Million USD | 22.64% |
| 2020 Q3 | 69.03 Million USD | 164.53% |
| 2020 Q4 | -111.23 Million USD | -261.13% |
| 2020 FY | -74.62 Million USD | -103.04% |
| 2020 Q2 | -106.97 Million USD | -240.69% |
| 2019 Q4 | 62 Million CAD | -89.59% |
| 2019 Q3 | 595.53 Million CAD | 211.34% |
| 2019 Q2 | 191.28 Million CAD | -40.3% |
| 2019 Q1 | 320.42 Million CAD | 4058.68% |
| 2019 FY | 2.45 Billion CAD | 17729.39% |
| 2018 Q2 | 549.72 Thousand CAD | 167.61% |
| 2018 Q1 | -813.06 Thousand CAD | -149.7% |
| 2018 Q3 | -5.58 Million CAD | -1115.13% |
| 2018 FY | -13.92 Million CAD | -803.1% |
| 2018 Q4 | -8.09 Million CAD | -45.05% |
| 2017 Q2 | 134.46 Thousand CAD | 121.24% |
| 2017 FY | 1.98 Million CAD | 323.73% |
| 2017 Q4 | 1.63 Million CAD | 84.93% |
| 2017 Q3 | 884.66 Thousand CAD | 557.92% |
| 2017 Q1 | -633.21 Thousand CAD | -159.63% |
| 2016 Q1 | -377.59 Thousand CAD | -123.24% |
| 2016 Q3 | -173.11 Thousand CAD | 87.84% |
| 2016 Q2 | -1.42 Million CAD | -277.16% |
| 2016 Q4 | 1.06 Million CAD | 713.4% |
| 2016 FY | -885.4 Thousand CAD | -418.17% |
| 2015 Q2 | -448.55 Thousand CAD | 24.93% |
| 2015 Q4 | 1.62 Million CAD | 542.15% |
| 2015 FY | 278.27 Thousand CAD | 106.7% |
| 2015 Q3 | -367.47 Thousand CAD | 18.08% |
| 2015 Q1 | -597.52 Thousand CAD | 0.0% |
| 2014 Q3 | -76.68 Thousand CAD | -697.61% |
| 2014 Q2 | -9613.92 CAD | 0.0% |
| 2014 FY | -4.15 Million CAD | -570.01% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 FY | -619.47 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 253.594% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -2287.034% |
| Embecta Corp. | 70.4 Million USD | 205.061% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 276.291% |
| PainReform Ltd. | -9.34 Million USD | -691.556% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -1541.418% |
| SCYNEXIS, Inc. | 67.04 Million USD | 210.325% |
| Journey Medical Corporation | -3.85 Million USD | -1819.621% |
| Safety Shot Inc | -15.08 Million USD | -390.372% |
| Alpha Teknova, Inc. | -36.78 Million USD | -101.096% |
| Bright Green Corporation | -13.12 Million USD | -463.414% |
| Procaps Group, S.A. | 42.54 Million USD | 273.867% |
| Alvotech | -551.73 Million USD | 86.594% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 493.86% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -839.809% |
| Cosmos Health Inc. | -18.54 Million USD | -298.88% |
| Dynavax Technologies Corporation | -6.38 Million USD | -1057.662% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 64.653% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 47.046% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -1541.418% |
| Theratechnologies Inc. | -23.95 Million USD | -208.732% |
| Harrow Health, Inc. | -24.41 Million USD | -202.99% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -1429.741% |
| Biofrontera Inc. | -20.13 Million USD | -267.408% |
| DURECT Corporation | -27.62 Million USD | -167.749% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 5720.289% |
| OptiNose, Inc. | -35.48 Million USD | -108.446% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 92.62% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | -75.272% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 409.262% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 1595.713% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 46902.25% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -1077.882% |
| Radius Health, Inc. | -25.79 Million USD | -186.778% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -1100.102% |
| ProPhase Labs, Inc. | -16.78 Million USD | -340.728% |
| Phibro Animal Health Corporation | 2.41 Million USD | 3161.382% |
| Procaps Group S.A. | 42.54 Million USD | 273.867% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -619.624% |
| Viatris Inc. | 54.7 Million USD | 235.216% |
| Rockwell Medical, Inc. | -8.43 Million USD | -776.443% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -366.82% |
| SIGA Technologies, Inc. | 68.06 Million USD | 208.659% |
| Tilray Brands, Inc. | -244.98 Million USD | 69.809% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 715.691% |
| Shineco, Inc. | -22.44 Million USD | -229.471% |
| PetIQ, Inc. | 2.13 Million USD | 3570.812% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -1619.335% |
| Incannex Healthcare Limited | -18.45 Million USD | -300.688% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 129.621% |
| Alimera Sciences, Inc. | -20.13 Million USD | -267.39% |
| Silver Spike Investment Corp. | 7.34 Million USD | 1107.655% |
| Assertio Holdings, Inc. | -331.94 Million USD | 77.718% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -1021.888% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -806.055% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | -313.224% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -268.758% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 53.853% |
| Hempacco Co., Inc. | -13.12 Million USD | -463.481% |
| Talphera, Inc. | -18.39 Million USD | -302.038% |
| Alvotech | -551.73 Million USD | 86.594% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 307.516% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 122.642% |
| Currenc Group, Inc. | -15.3 Million USD | -383.211% |
| Kamada Ltd. | 8.28 Million USD | 992.842% |
| Indivior PLC | 2 Million USD | 3798.15% |
| Evoke Pharma, Inc. | -7.79 Million USD | -849.181% |
| Flora Growth Corp. | -57.03 Million USD | -29.678% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -268.758% |
| Evolus, Inc. | -61.68 Million USD | -19.904% |
| HUTCHMED (China) Limited | 100.78 Million USD | 173.391% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 153.774% |
| Akanda Corp. | -32.27 Million USD | -129.164% |